BioHistory Moment: Iditarod Trail used to transport diphtheria serum to Nome.

In 1925, a life-or-death race to save the children of Nome from a diphtheria epidemic made an international hero of one sled dog, and led to the creation of Alaska's Iditarod sled dog race. A diphtheria epidemic threatened remotely located Nome, and air transportation was unavailable to transport serum from Anchorage nearly a thousand miles away.

The solution: A relay of dog teams transported serum on the Iditarod Trail from Nenana to Nome, and every village enroute provided its best team and driver for the next leg continually moving the serum toward Nome. Gunnar Kaasen, a Norwegian musher, drove the final two legs into Nome behind his lead dog Balto through a blizzard with 80 mph winds to deliver 300,000 units of diphtheria antitoxin to Dr. Curtis Welch, the only doctor in Nome.

The serum arrived in time, prevented the epidemic and saved hundreds of lives. The 20 mushers had covered nearly 700 miles in slightly more than 127 hours in temperatures of minus40° Fahrenheit below zero and strong winds. The serum run received worldwide press coverage and the mushers received special gold medals and other recognition. In 1926, a statue of Balto, the heroic lead dog, was erected in New York's Central Park.

Learn about Sacramento's Embarcadero Road Biotech/Medical Device Facility

Learn about biotechnology, medical device and pharmaceutical facilities available for sale, lease or sublease in Arizona, regionally or nationwide.

Industry News...

Free News Release Posting & Archiving Service


• Bruker and Agilent announce agreement for Bruker to acquire certain Varian products  Bruker and Agilent Technologies announced that Bruker and Agilent have entered into a definitive asset purchase agreement. Bruker will acquire certain product lines of Varian, which Agilent has committed to divest.
  Bruker Corporation  March 09, 2010  
  
  
• Abbott enhances pharmaceutical pipeline with acquisition of Facet Biotech  Abbott and Facet Biotech announced a definitive agreement for Abbott to acquire Facet, enhancing Abbott's early- and mid-stage pharmaceutical pipeline.
  Abbott  March 09, 2010  
  
  
• FDA Advisory Committee recommends approval of InterMune's Esbriet(R) (pirfenidone) for IPF  InterMune announced that the U.S. Food and Drug Administration's (FDA) Pulmonary-Allergy Drugs Advisory Committee (PADAC) voted 9-3 to recommend approval of Esbriet(R) (pirfenidone) for the treatment of patients with idiopathic pulmonary fibrosis (IPF) to reduce decline in lung function.
  InterMune, Inc.  March 09, 2010  
  
  
• Vaccinating children against flu helps protect wider community  Results of a clinical trial conducted in a largely self-contained religious community during the 2008-09 influenza season show that immunizing children against seasonal influenza can significantly protect unvaccinated community members against influenza as well.
  National Institutes of Health  March 09, 2010  
  
  
• InSite Vision reports full year and fourth quarter 2009 financial results  Revenues for the year ended December 31, 2009 were $9.8 million compared to $13.7 million for the same period in 2008. 2009 revenues included royalties from Inspire Pharmaceuticals of $8.0 million for sales of AzaSite compared to $3.6 million in 2008.
  InSite Vision Incorporated  March 09, 2010  
  
  

More... | Submit News Release | Advertising...

New Job Postings...

Free Job Posting Trial Offer

• Scientist/Senior Scientist, Formulations Seattle Genetics, Inc. (WA)
• Quality Assurance Validation Associate Seattle Genetics, Inc. (WA)
• Quality Assurance Manufacturing Associate Seattle Genetics, Inc. (WA)
• CMC Associate Project Manager Seattle Genetics, Inc. (WA)
• Drug Safety Specialist Seattle Genetics, Inc. (WA)

More... | Job Advertising... | About Job Postings...

New Facilities Available...

ATC clean room constructors...validation guaranteed!

• 890 Embarcadero Road Property -- West Sacramento, CA
• CompleGen Lab/Office Space -- Seattle, WA
• Life Sciences Incubator -- Seattle, WA
• University of Iowa Oakdale Research Park Biotech Building -- Coralville, IA
• University of Iowa Oakdale Research Park BioVentures Center -- Coralville, IA

More... | Facility Advertising...

Upcoming Events...

• 03/10/2010: Imaging in Oncology
• 03/10/2010: Online Webinar: Contamination Control Training
• 03/10/2010: Online Webinar: Mastering the Art of Clinical Monitoring
• 03/10/2010: Online Webinar: How to Comply With Recent Expectations
• 03/10/2010: Online Webinar: Medical Devices Directive 93/42/EEC

More... | Submit Event | Event Advertising...